Table 1.

General Characteristics of Study Group

Study Years	1996–2005
Total Adult Liver Transplants for HCV	385
Patients characterized for IL-28B	135
Patients treated with IFN therapy after LT	135
Age (years ± SE)	49 ± 7
Gender (F:M)	39:96
Race (C/H/AA/A)	112:11:9:3
HCV Genotype (%)
1	110 (85%)
2	7 (5%)
3	10 (8%)
4	1 (1%)
6	1 (1%)
HCC at transplant	21 (16%)
Mean Donor Age (years ± SE)	40.9 ± 1.7

HCV, hepatitis C infection; IL-28B, interleukin 28B; IFN, interferon; LT, liver transplant; SE, standard error; F, female; M, male; C, Caucasian; H, Hispanic; AA, African American; A, Asian; HCC, Hepatocellular carcinoma